Why is Brooks Lab. falling/rising?

As of 20-Aug, Brooks Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 150.50, which reflects a decrease of Rs 2.5 or 1.63%. The stock has underperformed its sector today by 1.21%, and trading has been erratic, with the stock not trading on one day out of the last 20. Although it reached an intraday high of Rs 156.85, the weighted average price indicates that more volume was traded closer to the low price. Additionally, the stock has shown a significant drop in delivery volume, falling by 86.75% against the 5-day average. Over the past week, the stock has decreased by 6.52%, and year-to-date, it has fallen by 18.63%, despite a strong performance over the long term with a 37.33% return in the last year.
In the broader market context, the Sensex has increased by 1.64% over the past week, contrasting with Brooks Laboratories' short-term decline. While the company has reported very positive results, including a 97.76% growth in net profit and strong sales figures, the recent performance has not translated into stock price stability. The stock's long-term performance remains strong, outperforming the BSE500 over the last three years, one year, and three months, but the current short-term trends and declining investor participation suggest a cautious outlook.